HDAC9 and Parkinson disease: Our findings show significant elevation of H4K12ac deposition along with dysregulation of HAT and HDAC in both chemical-induced and CRISPR-mediated mitochondrial dysfunction in cell models as well as MitoPark mouse model and postmortem human PD brains, demonstrating the potentially important role of H4K12ac in the pathophysiology of PD.